At a press briefing, Dr. Mehmet Oz, Centers for Medicare and Medicaid Services Administrator, celebrated President Trump's executive order on bringing down drug pricing.

We recently analyzed data from a nationally representative study of approximately 6,000 people who had Medicaid coverage but ...

The health care conglomerate is facing mounting financial problems – and ongoing consumer anger over high costs and denied ...

Still, the new forecast is below the 2025 COLA of 2.5% and the average COLA over the past 20 years of 2.6%. It would be the lowest since 2021, when the increase was 1.3%. COLA is not a raise, but ...

"The company suspended its 2025 outlook as care activity continued to accelerate while also broadening to more types of benefit offerings than seen in the first quarter, and the medical costs of many ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

AARP also calls on Congress to protect and strengthen Medicare’s ability to negotiate lower drug prices for millions of older ...

UnitedHealth CEO exits amid Medicare losses and market shock raising concerns about leadership strategy and industry-wide ...

May 13 (UPI) -- UnitedHealth Group announced Tuesday CEO Andrew Witty will step down, citing "personal reasons." Witty will ...

CMS proposed several changes for the third round of Medicare drug price negotiations, including the potential inclusion of some drugs under Medicare Part B, in a draft guidance published May 12. The ...

UnitedHealth Group Incorporated stock drops after a rare earnings miss and CEO resignation. Click for the impact and ...

The U.S. Department of Health and Human Services announced plans to develop a platform using Medicare and Medicaid records to investigate the causes of autism.